As Nvidia Launches New Nemotron 3 Models, Should You Buy, Sell, or Hold NVDA Stock?

Core Viewpoint - Nvidia is positioned as a leading AI infrastructure company, with strong growth potential reflected in its premium valuation compared to the sector average, driven by its innovative products and strategic partnerships [1][4]. Financial Performance - Nvidia reported record revenue of $57 billion for Q3, marking a 22% increase quarter-over-quarter and a 62% increase year-over-year, primarily due to data center revenue of $51.2 billion [8]. - The company's gross margins remained high at 73.4% GAAP and 73.6% non-GAAP, with earnings per share (EPS) at $1.30 [8]. - Nvidia returned $37 billion through buybacks and dividends in the first nine months of fiscal 2026, with an additional $62.2 billion authorized for repurchases [8]. Market Position and Valuation - Nvidia's forward price-to-earnings (P/E) ratio stands at 40x, significantly higher than the sector's 24.34x, indicating market expectations for faster growth and stronger long-term earnings [1]. - The company's market capitalization is approximately $4.15 trillion, although shares have fallen over 17% from recent highs, reflecting investor concerns about the sustainability of AI spending [5]. Product Development and Innovation - The launch of the Nemotron 3 family of open models aims to enhance agentic AI development, with the Nemotron 3 Nano model delivering four times the throughput of its predecessor [6][10]. - Nvidia's collaboration with Synopsys focuses on integrating AI and accelerated computing into engineering workflows, enhancing design and simulation processes [9]. Strategic Partnerships - Nvidia has invested $2 billion in Synopsys to strengthen its commitment to AI in engineering [10]. - Partnerships with HUMAIN and Upwind aim to expand Nvidia's infrastructure capabilities and secure AI workloads, respectively [10][12]. Analyst Outlook - For Q4 of fiscal 2026, Nvidia expects revenue of about $65 billion, with EPS estimates showing significant year-over-year growth [13]. - Analysts remain optimistic, with price targets ranging from $250 to $350, indicating potential upside from current levels [14][15].